After double-dose IFN-β injections in stable CR, serum vitamin D correlated with decreased Th1 cytokines and with increased Th2 cytokines (Fig 13B), suggesting an additive immunoregulatory benefit of IFN-β and vitamin D in stable MS. The gene discussed is IFNB1; the disease is myeloid sarcoma.